Key result
Myotubes from patients with an accelerated Ca-induced Ca release rate had significantly lower EC50 values for caffeine, halothane, and 4-chloro-m-cresol (P<0.001).
Why the study?
Does the sensitivity of human cultured myotubes to ryanodine receptor type 1 activators identify predisposition to malignant hyperthermia?
Observational (n=34)
Does the sensitivity of human cultured myotubes to ryanodine receptor type 1 activators identify predisposition to malignant hyperthermia?
p-value: p=<0.001
Functional testing of human cultured myotubes for sensitivity to ryanodine receptor type 1 activators may help identify predisposition to malignant hyperthermia.
Malignant hyperthermia is a life-threatening condition caused by autosomal dominant mutations in the ryanodine receptor type 1 gene. Identifying patients predisposed to malignant hyperthermia is done through the Ca-induced Ca release test in Japan. We examined the intracellular calcium concentration in human cultured muscle cells and compared the sensitivity of myotubes to ryanodine receptor type 1 activators based on the Ca-induced Ca release rate. We assessed the utility of this method as an identifying test for predisposition to malignant hyperthermia. Muscle specimens were obtained from 34 individuals undergoing the Ca-induced Ca release test. We cultured myotubes from residual material and monitored changes in intracellular calcium concentration after exposure to the ryanodine receptor type 1 activators caffeine, halothane and 4-chloro-m-cresol by measuring fura-2 fluorescence. We determined the half maximal effective concentrations (EC50) for the test compounds in each myotube and calculated cut-off points using receiver operating characteristic curves. Seventeen patients each were classified into the accelerated and non-accelerated groups based on their Ca-induced Ca release rate. The EC50 values for caffeine, halothane and 4-chloro-m-cresol of the accelerated group were significant lower than those of the non-accelerated group (P < 0.001, P < 0.001 and P < 0.001, respectively). The calculated cut-off points of EC50 values for caffeine, halothane and 4-CmC were 3.62 mM, 2.28 mM and 197 microM, respectively. An increased sensitivity to ryanodine receptor type 1 activators was seen in myotubes in the accelerated group. This functional test on human cultured myotubes indicates that the alteration of their intracellular Ca2+ homeostasis may identify the predisposition to malignant hyperthermia.
No takes yet. Share an insight, caveat, or question.
Kobayashi et al. (2011) conducted an observational in Malignant hyperthermia (n=34). Accelerated Ca-induced Ca release rate vs. Non-accelerated Ca-induced Ca release rate was evaluated on Half maximal effective concentrations (EC50) for caffeine, halothane and 4-chloro-m-cresol (p=<0.001). Myotubes from patients with an accelerated Ca-induced Ca release rate had significantly lower EC50 values for caffeine, halothane, and 4-chloro-m-cresol (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: